Lumos

LDX.AX

Tags: AU Healthcare Medical - Diagnostics & Research

Lumos Diagnostics Holdings Limited Price (LDX.AX)

Stock Price

Low: Year Low

High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Shares Outstanding

463,193,771

(97.2352)%

Market Cap of Lumos (LDX.AX)

Market cap:

As of , LDX.AX has a market cap of . This makes LDX.AX the 947th most valuable company in the AU by market cap. Market capitalization, or market cap, is the total value of a company's outstanding shares of stock, calculated by multiplying the current stock price by the total number of shares.

Year

Beginning Of Year

End Of Year

YOY Change

Community Sentiment 0 votes

↑ 0% ↓ 0%

Description

Lumos Diagnostics Holdings Limited, a contract research and development company, develops and commercializes rapid point-of-care (POC) diagnostic tests which are primarily focuses on the diagnosis and management of infectious diseases in the United States and Australia. The company products include FebriDx, a POC diagnostic test for detecting and differentiating viral and bacterial respiratory infections; ViraDx, a three-in-one POC test for influenza A, influenza B, and COVID-19.; and CoviDx, a rapid antigen test for COVID-19. It also offers desktop read... Read More

Sector: Healthcare

Previous Close Fetching Data...
Range $0.02-0.069
Market Cap 16.47M
Enterprise Value No Data
Avg Volume Fetching Data...
P/E Ratio Fetching Data...
Dividend Yield Fetching Data...

Industry: Medical - Diagnostics & Research

ceo: Mr. Douglas Ward
IPO Date: July, 05, 2021
Country: AU
Currency: AUD
Headquaters: Melbourne, VIC
Employees: No Data

- Revenue from each product or segment:

Product or Segment	Value:	% - Total	Last 3Y:

- Revenue by Region

Product or Segment	Value:	% - Total	Last 3Y: